what is glp 1 activator GLP-1 What is GLP-1 and Its

Rapid weight loss with GLP1 receptor agonists can come at the cost of skeletal muscle, potentially undermining metabolic and functional outcomes

helps you reach both goals

Retatrutide, a novel triple GLP-1/GIP/glucagon receptor agonist, typically shows measurable metabolic changes within 24 weeks, with weight loss acceleration by 812 weeks

We do more than just prescribe medication

Promotes a healthy blood sugar response*: Reducose slows down the breakdown of carbs to reduce post-meal glucose spikes by up to 40%, while Feiolix supports insulin sensitivity and glucose metabolism.

Joel Habener, a retired longtime endocrinologist at MGH, and Svetlana Mojsov, a former chemist at the hospital, will share the $250,000 award with a third researcher.